Mitchell Denker

749 total citations
5 papers, 38 citations indexed

About

Mitchell Denker is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mitchell Denker has authored 5 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mitchell Denker's work include Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Mitchell Denker is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Ferroptosis and cancer prognosis (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Mitchell Denker collaborates with scholars based in United States, India and United Kingdom. Mitchell Denker's co-authors include Priti S. Hegde, Duy Phu Tran, Luciana Molinero, Chien‐Wen Chang, Colombe Chappey, Edward E. Kadel, Yohann Loriot, Zachary Boyd, Charles G. Drake and Hartmut Koeppen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Mitchell Denker

5 papers receiving 38 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mitchell Denker United States	4	35	16	11	11	7	5	38
Jiyu Wen China	3	36 1.0×	14 0.9×	7 0.6×	5 0.5×	11 1.6×	6	48
Irina Rozhkova Poland	4	47 1.3×	39 2.4×	8 0.7×	7 0.6×	6 0.9×	4	55
Li‐Hsin Chien Taiwan	4	21 0.6×	10 0.6×	5 0.5×	5 0.5×	4 0.6×	5	34
Leilana Ly United States	4	54 1.5×	9 0.6×	12 1.1×	6 0.5×	12 1.7×	8	61
Chaudhary E. Ahmad Canada	2	54 1.5×	6 0.4×	7 0.6×	7 0.6×	12 1.7×	5	56
M. Ignatiadis Belgium	4	17 0.5×	7 0.4×	5 0.5×	11 1.0×	7 1.0×	6	27
Blanca Ledezma United States	5	49 1.4×	17 1.1×	12 1.1×	7 0.6×	2 0.3×	11	52
Andressa Dias Costa United States	4	29 0.8×	6 0.4×	11 1.0×	5 0.5×	8 1.1×	14	50
Karina Vianna Brazil	4	36 1.0×	19 1.2×	7 0.6×	4 0.4×	3 0.4×	6	40
Muhammad Saad Hamid United States	4	15 0.4×	19 1.2×	6 0.5×	3 0.3×	5 0.7×	10	36

Countries citing papers authored by Mitchell Denker

Since Specialization

Citations

This map shows the geographic impact of Mitchell Denker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell Denker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell Denker more than expected).

Fields of papers citing papers by Mitchell Denker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell Denker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell Denker. The network helps show where Mitchell Denker may publish in the future.

Co-authorship network of co-authors of Mitchell Denker

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell Denker. A scholar is included among the top collaborators of Mitchell Denker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell Denker. Mitchell Denker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Chang, Chien‐Wen, et al.. (2018). Abstract PD6-01: Prevalence of PDL1 and tumor infiltrating lymphocytes (TILs) in primary and metastatic TNBC. Cancer Research. 78(4_Supplement). PD6–1. 12 indexed citations

2.

Powles, Thomas, Dorothee Nickles, Eliezer M. Van Allen, et al.. (2015). Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC). Journal for ImmunoTherapy of Cancer. 3(S2). 11 indexed citations

3.

Gettinger, Scott, Marcin Kowanetz, Hartmut Koeppen, et al.. (2015). Molecular, immune and histopathological characterization of NSCLC based on PDL1 expression on tumor and immune cells and association with response to the anti-PDL1 antibody MPDL3280A.. Journal of Clinical Oncology. 33(15_suppl). 3015–3015. 10 indexed citations

4.

Xiao, Yuanyuan, Christina Rabe, Marcin Kowanetz, et al.. (2014). Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer (UBC). 5. 1 indexed citations

5.

Xiao, Yuanyuan, Christina Rabe, Marcin Kowanetz, et al.. (2014). Myeloid cell biology and inhibition of anti-tumor immune responses by MPDL3280A in urothelial bladder cancer. Journal for ImmunoTherapy of Cancer. 2(S3). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact